Search results for "CEM"

showing 10 items of 3487 documents

Liraglutide Improves Cardiovascular Risk as an Add-on to Metformin and Not to Insulin Secretagogues in Type 2 Diabetic Patients: A Real-life 48-Month…

2017

INTRODUCTION: Although liraglutide is widely recognized to have glycemic and extra-glycemic effects, few studies have compared these effects in relation to hypoglycemic treatment starting from the diagnosis of diabetes. We evaluated the effectiveness of liraglutide in reducing the Framingham risk score (FRS) and visceral adiposity index (VAI) in relation to first-line hypoglycemic treatment from diagnosis of type 2 diabetes, continued without any changes. METHODS: We selected 105 diabetic outpatients who were treated with liraglutide for at least 48 months as an add-on therapy to metformin alone (group A, n = 52) or insulin secretagogues (group B, n = 53) from diagnosis time. RESULTS: Altho…

medicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatment030209 endocrinology & metabolismType 2 diabetes030204 cardiovascular system & hematologyGastroenterologySettore MED/13 - Endocrinologia03 medical and health sciences0302 clinical medicineDiabetes mellitusInternal medicineInternal MedicinemedicineGlycemicFramingham Risk Scorebusiness.industryLiraglutideBrief ReportInsulinDiabetesLiraglutideCardiovascular riskmedicine.diseaseliraglutide diabetesMetforminEndocrinologyBlood pressureVisceral adipositybusinessmedicine.drug
researchProduct

A multinational, multidisciplinary consensus for the diagnosis and management of spinal cord compression among patients with mucopolysaccharidosis VI.

2012

Cervical cord compression is a sequela of mucopolysaccharidosis VI, a rare lysosomal storage disorder, and has devastating consequences. An international panel of orthopedic surgeons, neurosurgeons, anesthesiologists, neuroradiologists, metabolic pediatricians, and geneticists pooled their clinical expertise to codify recommendations for diagnosing, monitoring, and managing cervical cord compression; for surgical intervention criteria; and for best airway management practices during imaging or anesthesia. The recommendations offer ideal best practices but also attempt to recognize the worldwide spectrum of resource availability. Functional assessments and clinical neurological examinations …

medicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentConsensus Development Conferences as TopicMucopolysaccharidosis type VIBiochemistryMyelopathyEndocrinologySpinal cord compressionGeneticsMedicineHumansIntensive care medicineMolecular BiologyMucopolysaccharidosis VIbusiness.industryStandard treatmentSequelaCervical cord compressionEnzyme replacement therapymedicine.diseaseSurgeryPractice Guidelines as TopicCervical VertebraeAirway managementbusinessSpinal Cord CompressionMolecular genetics and metabolism
researchProduct

Similar efficacy of low and standard doses of transdermal estradiol in controlling bone turnover in postmenopausal women

2006

To investigate the effects of a low transdermal estradiol dose on bone metabolism and to compare it with both the standard dose and absence of treatment.In this study performed in a third-level academic center, 66 healthy postmenopausal women underwent hormone therapy (HT) with patches containing estradiol at standard (0.050 mg/day, HT50, 33 women) or low dosage (0.025 mg/day, HT25, 33 women) and 70 women were without treatment (NT). The values (mean of three samples) of several bone biochemical parameters were compared between groups after adjusting for confounding factors. Bone mineral density (BMD) was assessed (by dual-energy X-ray absorptiometry) in the spine and hip in all cases, and …

medicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentOsteoporosisCollagen Type IBone remodelingEndocrinologyBone DensityInternal medicinemedicineHumansOsteoporosis PostmenopausalTransdermalBone mineralAnalysis of VarianceDose-Response Relationship DrugEstradiolbusiness.industryEstrogen Replacement TherapyObstetrics and GynecologyMiddle AgedAlkaline Phosphatasemedicine.diseasePostmenopauseMenopauseDose–response relationshipEndocrinologyFemaleHormone therapyPeptidesDensitometrybusinessBiomarkersGynecological Endocrinology
researchProduct

Vascular aging in women: is estrogen the fountain of youth?

2012

Aging is a physiological process associated with structural and functional changes in vasculature, including endothelial dysfunction, arterial stiffening and remodeling, impaired angiogenesis, and defective vascular repair, and with an increasing prevalence of atherosclerosis. The risk of cardiovascular disease differs between men and women, remaining lower in women during their fertile years and reaching values similar to their male peers after menopause. Menopause is marked by the loss of endogenous estrogen production. Therefore, estrogens have been implicated in premenopausal protection from cardiovascular disease, an assumption supported by experimental and some clinical studies, where…

medicine.medical_specialtyEndotheliumPhysiologymedicine.drug_classThromboxaneAngiogenesismedicine.medical_treatmentProstacyclinReview ArticleNitric Oxidelcsh:PhysiologyVascular protectionPhysiology (medical)Internal medicinemedicineEndotheliumEndothelial dysfunctionSistema cardiovascularEstradiollcsh:QP1-981Artèriesbusiness.industryHormone replacement therapy (menopause)Endoteli vascularmedicine.diseaseMenopauseEndocrinologymedicine.anatomical_structureEstrogenMenopausebusinessmedicine.drug
researchProduct

Association between Proinflammatory Markers, Leukocyte–Endothelium Interactions, and Carotid Intima–Media Thickness in Type 2 Diabetes: Role of Glyce…

2020

Glycated hemoglobin monitorization could be a tool for maintaining type 2 diabetes (T2D) under control and delaying the appearance of cardiovascular events. This cross-sectional study was designed to assess the role of glycemic control in modulating early-stage markers of cardiovascular complications. One hundred and eight healthy controls and 161 type 2 diabetic patients were recruited and distributed according to their glycemic control, setting the threshold at 6.5% (good control). Biochemical and anthropometrical parameters were registered during the initial visit, and peripheral blood was extracted to obtain polymorphonuclear cells and analyze inflammatory markers, adhesion molecules, l…

medicine.medical_specialtyEndotheliumPopulationlcsh:MedicineInflammationType 2 diabetes030204 cardiovascular system & hematologyGastroenterologyArticleProinflammatory cytokine03 medical and health scienceschemistry.chemical_compound0302 clinical medicineendothelial functionInternal medicinemedicineeducationcarotid intima–media thickness030304 developmental biologyGlycemic0303 health scienceseducation.field_of_studybusiness.industrylcsh:RGeneral Medicinemedicine.diseasemedicine.anatomical_structurechemistryIntima-media thicknessinflammationGlycated hemoglobintype 2 diabetesmedicine.symptombusinessglycated hemoglobinJournal of Clinical Medicine
researchProduct

Mutations in the Factor XII Gene in Solitary Cases of Recurrent Angioedema with Normal C1 Inhibitor Induced or Worsened by Oral Contraceptives or Hor…

2012

medicine.medical_specialtyFactor XIIAngioedemabiologybusiness.industryImmunologyHormonal replacement therapyC1-inhibitorEndocrinologyInternal medicinemedicinebiology.proteinImmunology and Allergymedicine.symptombusinessGeneJournal of Allergy and Clinical Immunology
researchProduct

Acid Ceramidase Deficiency

2015

Abstract A deficiency of the lysosomal enzyme ceramidase leads to accumulation of the sphingolipid ceramide in several organs such as skin, liver, brain and other tissues, resulting in a broad spectrum of clinical manifestations. The most common form, called Farber lipogranulomatosis, is characterized by subcutaneous skin nodules and a progressive hoarseness, in many cases also the central nervous system is affected. A lethal hydrops fetalis represents the most severe form. A ceramidase deficiency was also found in a few patients in whom neurological symptoms such as spinal muscular atrophy and myoclonus epilepsy dominated the clinical picture. In the ceramidase gene, which has been mapped …

medicine.medical_specialtyFarber diseasePathologyGenetic enhancementCentral nervous systemProgressive myoclonus epilepsySpinal muscular atrophyBiologyCeramidasemedicine.diseaseSphingolipidEndocrinologymedicine.anatomical_structureHydrops fetalisInternal medicinemedicine
researchProduct

Cardiac complications after laparoscopic large hiatal hernia repair. Is it related with staple fixation of the mesh? -Report of three cases

2015

Introduction Laparoscopic Nissen operation with mesh reinforcement remains being the most popular operation for large hiatal hernia repair. Complications related to mesh placement have been widely described. Cardiac complications are rare, but have a fatal outcome if they are misdiagnosed. Presentation of cases We sought to outline our institutional experience of three patients who developed cardiac complications following a laparoscopic Nissen operation for large hiatal hernia repair. Discussion Laparoscopic hiatoplasty and Nissen fundoplication are safe and effective procedures for the hiatal hernia repair, but they are not exempt from complications. Fixation technique and material used m…

medicine.medical_specialtyFatal outcomebusiness.industryNissen operationGeneral MedicineMesh hiatoplastymedicine.diseasedigestive system diseasesSurgeryGiant hiatal herniaMesh fixationFixation (surgical)surgical procedures operativeCardiac tamponadeCardiac complicationsmedicineSurgeryMesh fixationMesh reinforcementbusinessCardiac tamponadeLarge hiatal herniaOriginal ResearchAnnals of Medicine & Surgery
researchProduct

401Prognostic role of late gadolinium enhancement in patients with low-intermediate 5 year HCM SCD risk score: a multicenter study

2018

medicine.medical_specialtyFramingham Risk ScoreMulticenter studybusiness.industryInternal medicinemedicineLate gadolinium enhancementIn patientCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal
researchProduct

324Prognostic role of late gadolinium enhancement in patients with low or intermediate HCM SCD risk score: a multicenter study

2019

medicine.medical_specialtyFramingham Risk Scorebusiness.industryGadoliniumchemistry.chemical_elementGeneral MedicinechemistryMulticenter studyInternal medicineCardiologyMedicineLate gadolinium enhancementRadiology Nuclear Medicine and imagingIn patientCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal - Cardiovascular Imaging
researchProduct